AlloVir (NASDAQ:ALVR) Cut to Neutral at Piper Sandler

Piper Sandler cut shares of AlloVir (NASDAQ:ALVR – Free Report) from an overweight rating to a neutral rating in a report published on Friday, MarketBeat reports. Separately, JPMorgan Chase & Co. lowered shares of AlloVir from an overweight rating to an underweight rating in a research note on Friday. One analyst has rated the stock […]

Leave a Reply

Your email address will not be published.

Previous post Deckers Outdoor (NYSE:DECK) Price Target Increased to $625.00 by Analysts at Wells Fargo & Company
Next post Ross Stores (NASDAQ:ROST) Price Target Increased to $150.00 by Analysts at Wells Fargo & Company